Skip to main content

Table 4 Re-classification decisions concerning the major efficacy outcome

From: A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project

 

Situations

Classification

Comments/Date of event

Treatment phase

 1

Two cultures + vea at the end of the treatment phase

Unfavorable

Last scheduled day of the treatment

 2

One culture + ve + second culture not done or contaminated

Unfavorable

Last scheduled day of the treatment

Death

 3

Death: no information suggesting it was not related to TB

Unfavorable

Date of death occurrence

 4

Death: documented evidence that it was not related to TB (for example, car accident)

Unfavorable

Date of death occurrence

Withdrawals (other than death and before the end of treatment)

 5

SAEb for which treatment is stopped

Unfavorable

Date when TB treatment stopped

 6

Pregnancy (so treatment is stopped)

Not assessable

Date when TB treatment stopped

 7

Patient withdrawal of consent

Unfavorable

Date of withdrawal

Follow-up phase c

 1

Culture -ve + data available for all visits or data available for last follow-up visit

Favorable

Date of last culture -ve

 2

Two cultures + ve (at least 1 day apart) during follow-up and organism id is Mtb

Unfavorable

Date of the first sampling with culture + ve

 3

One culture + ve and organism id is Mtb + second culture not done or contaminated

Unfavorable

Date of the sampling with the culture + ve

 4

Death and one culture + ve based on most recent culture result and organism id is Mtb

Unfavorable

Date of the sampling with culture + ve

 5

Death and culture -ve based on most recent culture result (or contaminated)

Not assessable or Unfavorable

Endpoint committee reviews available data

Withdrawals (other than death):

 6

Patient withdrawal of consent and one culture + ve based on most recent culture result

Unfavorable

Date of the sampling with culture + ve

 7

Patient withdrawal of consent and culture -ve based on most recent culture result (or contaminated)

Non-assessable for the period after being withdrawn

Favorable till the date of last culture -ve/Non-assessable the day after the last visit

 8

Lost during follow-up/moved away from area and one culture + ve based on most recent culture result

Unfavorable

Date of the sampling with culture + ve

 9

Lost during follow-up/moved away from area and culture -ve based on most recent culture result (or contaminated)

Non-assessable for the period after being withdrawn

Favorable till the date of last culture -ve

Non-assessable the day after the last visit

  1. aPositive.
  2. bSerious adverse event.
  3. cDefined among those patients classified as cured at the end of the treatment phase. Cure is defined as two consecutive negative cultures.